CD58 and endometrial cancer: Several of the increased (SNCA, CDKN3, CD58) or decreased (PIBF1, MICB) DEGs have been previously described in endometriosis, endometrial cancer, and other gynecological pathologies as being specifically involved in delayed decidualization and inflammation21–24.